Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects

NCT01646814 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroduodenal Ulceration

Interventions

DRUG: PL2200
DRUG: Aspirin tablets

Sponsor

PLx Pharma